TY - JOUR
T1 - Caught in vicious circles
T2 - a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
AU - Cuenod, Michel
AU - Steullet, Pascal
AU - Cabungcal, Jan Harry
AU - Dwir, Daniella
AU - Khadimallah, Ines
AU - Klauser, Paul
AU - Conus, Philippe
AU - Do, Kim Q.
N1 - Funding Information:
We thank Dr. Byron Bitanihirwe for his excellent assistance with the preparation of the manuscript, Morgane Baumgartner, Adeline Cottier and Gloria Reuteler for their helpful technical assistance, and Dr Fulvio Magara and the technical staff of the “Centre d’Etudes du Comportement” (Center for Psychiatric Neuroscience, CHUV) for their support in animal facilities. We also thank Martine Cleusix, Raoul Jenny, Dr Alessandra Solida and all the staff of the Minkowski Section for the recruitment and clinical evaluation of patients. Last but not least, we are grateful to all patients for their precious participation. Swiss National Science Foundation (# 31-116689 to KQD and # 310030_135736/1 to KQD and PS), National Center of Competence in Research (NCCR) “SYNAPSY - The Synaptic Bases of Mental Diseases” from the Swiss National Science Foundation (n° 51AU40_185897 to KQD &PC), Avina Foundation, Damm-Etienne Foundation, and Alamaya Foundation.
Publisher Copyright:
© 2021, The Author(s).
PY - 2022/4
Y1 - 2022/4
N2 - A growing body of evidence has emerged demonstrating a pathological link between oxidative stress and schizophrenia. This evidence identifies oxidative stress as a convergence point or “central hub” for schizophrenia genetic and environmental risk factors. Here we review the existing experimental and translational research pinpointing the complex dynamics of oxidative stress mechanisms and their modulation in relation to schizophrenia pathophysiology. We focus on evidence supporting the crucial role of either redox dysregulation, N-methyl-D-aspartate receptor hypofunction, neuroinflammation or mitochondria bioenergetics dysfunction, initiating “vicious circles” centered on oxidative stress during neurodevelopment. These processes would amplify one another in positive feed-forward loops, leading to persistent impairments of the maturation and function of local parvalbumin-GABAergic neurons microcircuits and myelinated fibers of long-range macrocircuitry. This is at the basis of neural circuit synchronization impairments and cognitive, emotional, social and sensory deficits characteristic of schizophrenia. Potential therapeutic approaches that aim at breaking these different vicious circles represent promising strategies for timely and safe interventions. In order to improve early detection and increase the signal-to-noise ratio for adjunctive trials of antioxidant, anti-inflammatory and NMDAR modulator drugs, a reverse translation of validated circuitry approach is needed. The above presented processes allow to identify mechanism based biomarkers guiding stratification of homogenous patients groups and target engagement required for successful clinical trials, paving the way towards precision medicine in psychiatry.
AB - A growing body of evidence has emerged demonstrating a pathological link between oxidative stress and schizophrenia. This evidence identifies oxidative stress as a convergence point or “central hub” for schizophrenia genetic and environmental risk factors. Here we review the existing experimental and translational research pinpointing the complex dynamics of oxidative stress mechanisms and their modulation in relation to schizophrenia pathophysiology. We focus on evidence supporting the crucial role of either redox dysregulation, N-methyl-D-aspartate receptor hypofunction, neuroinflammation or mitochondria bioenergetics dysfunction, initiating “vicious circles” centered on oxidative stress during neurodevelopment. These processes would amplify one another in positive feed-forward loops, leading to persistent impairments of the maturation and function of local parvalbumin-GABAergic neurons microcircuits and myelinated fibers of long-range macrocircuitry. This is at the basis of neural circuit synchronization impairments and cognitive, emotional, social and sensory deficits characteristic of schizophrenia. Potential therapeutic approaches that aim at breaking these different vicious circles represent promising strategies for timely and safe interventions. In order to improve early detection and increase the signal-to-noise ratio for adjunctive trials of antioxidant, anti-inflammatory and NMDAR modulator drugs, a reverse translation of validated circuitry approach is needed. The above presented processes allow to identify mechanism based biomarkers guiding stratification of homogenous patients groups and target engagement required for successful clinical trials, paving the way towards precision medicine in psychiatry.
UR - http://www.scopus.com/inward/record.url?scp=85118839473&partnerID=8YFLogxK
U2 - 10.1038/s41380-021-01374-w
DO - 10.1038/s41380-021-01374-w
M3 - Review Article
C2 - 34759358
AN - SCOPUS:85118839473
SN - 1359-4184
VL - 27
SP - 1886
EP - 1897
JO - Molecular Psychiatry
JF - Molecular Psychiatry
ER -